Monday, August 3, 2015

Eagle Pharmaceuticals - Barchart Chart of the Day

Eagle Pharmaceuticals (EGRX) is the Barchart Chart of the Day,  The pharmaceutical company has a Trend Spotter buy signal, a Weighted Alpha of 854.77+ and gained 571.66% in the last year.

The Chart of the Day belongs to Eagle Pharmaceutical (EGRX).  I found the pharmaceutical stock by using Barchart to sort the All Time High list for the stock with the highest Weighted Alpha then used the Flipchart feature to review the charts.  Since the Trend Spotter signaled another buy on 7/10 the stock gained another 12.66%.

Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.


The status of Barchart's Opinion trading systems are listed below.  Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates.  The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

Barchart technical indicators:

  • 96% Barchart technical buy signals
  • 571.66+ Weighted Alpha
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 10 new highs and up 28.48% in the last month
  • Relative Strength Index 62.95%
  • Barchart computes a technical support level at 92.87
  • Recently traded at 96.05 with a 50 day moving average of 82.37
Fundamental factors:
  • Market Cap $1.46 billion
  • P/E 1,613
  • Revenue expected to increase 245.50% next year
  • Earnings estimated to increase 704.80% next year
  • Wall Street analysts issued 1 strong buy and 3 buy recommendations
The 50-100 Day MACD Oscillator has been an extremely good technical trading strategy for this stock.

No comments:

Post a Comment